Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...
SAN DIEGO - Boundless Bio (NASDAQ:BOLD) reported a fourth quarter loss of -$0.58 per share, beating analyst estimates of -$1.16 per share, as the clinical-stage oncology company opened enrollment for ...
Jackson Hospital & Clinic, Alabama, bondholders are being offered what would be, at best, an 18.7% recovery for the par ...
The University of Georgia announced on Friday the admission of more than 15,400 students to the class of 2030, including from 156 of Georgia’s 159 counties, according to a UGA ...
Future endeavors took center stage at the March 9 McCook School Board meeting, as board members discussed upcoming trips, facility repairs, school improvement goals and potential legislation. With the ...
Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...
NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...
Earnings call BioNTech delivered EUR 2.9 billion in 2025 revenue, surpassing guidance despite declining COVID-19 vaccine sales, aided by BMS collaboration payments. 2026 guidance targets EUR 2.0–2.3 ...
Making money online with video isn't only for people with fancy gear or editing skills. With a Free AI Video Generator like InVideo AI, you can go from an ...
Dr. Zonghai Li, Founder, Chairman of the Board, Chief Executive Officer, and Chief Scientific Officer of CARsgen Therapeutics, said, "2025 is a pivotal year for CARsgen Therapeutics. As we enter the ...
6d
AbCellera Biologics Inc. (ABCL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsMartin Hogan - Senior Director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results